TopiVert receives IND approval for TOP1630 in the treatment of dry eye syndrome
LONDON, UNITED KINGDOM--(Marketwired - Nov 28, 2016) - TopiVert Pharma Ltd ("TopiVert" or the "Company"), a clinical-stage biotechnology company developing Narrow Spectrum Kinase Inhibitors (NSKIs) as novel, locally-acting medicines …